Genky DrugStores Co., Ltd.

Genky DrugStores Co., Ltd. (9267.T) Cash Flow Analysis
Genky DrugStores Co., Ltd. operates in the Healthcare sector as part of the Medical - Pharmaceuticals industry. The company is currently trading at 4605.00 with a market capitalization of N/A.
Cash Flow Overview
Cash flow analysis provides insights into Genky DrugStores Co., Ltd.'s financial health by examining how the company generates and uses cash. This analysis covers three main categories: operating activities, investing activities, and financing activities.
Key Cash Flow Metrics
Financial Position Indicators
Stock Performance Summary
The data below highlights Genky DrugStores Co., Ltd.'s results over various time intervals.
Company Information
Investment Metrics
Understanding Cash Flow Statements
These statements detail the actual movement of money through a business, what comes in and what goes out. Cash flow reports exclude accruals, giving a cash-only perspective that income statements often don't provide.
Three Components of Cash Flow:
Operating Activities
Operating activities generate company's cash flow
Investing Activities
Money directed toward securities, acquisitions, or long-term asset investments
Financing Activities
Money sourced through financing, equity sales, and dividends
Data Update: Financial data is updated regularly based on company filings. Last earnings announcement: October 28, 2025.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: JPY. Exchange: JPX.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.
Genky DrugStores Co., Ltd. (9267.T) Cash Flow Analysis
The cash flow statement reveals the Genky DrugStores Co., Ltd. (9267.T) liquidity trends, with operating cash flow per share at $0.00, reflecting core business performance. Investing activity changes were N/A, indicating capital expenditures or asset sales, while financing activity shifted by N/A, showing debt or equity movements. Free cash flow per share was $0.00, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is N/A, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan